Leerink Raises Price Target as Roivant (ROIV) Accelerates Drug Development Pipeline

1 week ago 9

Sheryar Siddiq

Fri, January 2, 2026 astatine 9:50 AM CST 2 min read

Roivant Sciences Ltd. (NASDAQ:ROIV) ranks among the best stocks nether $25 to bargain now. Following the company’s expert gathering connected December 11, Leerink Partners boosted its terms people for Roivant Sciences Ltd. (NASDAQ:ROIV) to $32 from $29, keeping an Outperform standing connected the company’s shares. The steadfast highlighted little estimated operational expenses successful the years up than antecedently modeled, resulting successful reduced expected losses and important profitability opening successful fiscal twelvemonth 2029.

By the extremity of 2028, Roivant’s “Next 36 Month vision” anticipates astatine slightest 3 commercialized launches, 4 oregon much NDA/BLA submissions, nary little than 8 important readouts, and astatine slightest 3 proof-of-concept evaluations.

Roivant Sciences Ltd. (NASDAQ:ROIV) has besides precocious the improvement schedules for its superior therapeutic candidates, including brepocitinib, with a New Drug Application filing for dermatomyositis slated successful aboriginal 2026 on with a imaginable commercialized motorboat successful aboriginal 2027. Furthermore, the Phase III proceedings for brepocitinib successful non-infectious uveitis has reached afloat enrollment up of time, with topline results expected successful the 2nd fractional of 2026.

Roivant Sciences Ltd. (NASDAQ:ROIV) is simply a clinical-stage biopharmaceutical institution that discovers, develops, and commercializes medicines and technologies. Its objective merchandise candidates see IMVT-1402, an antibody that targets the neonatal Fc receptor for the attraction of Graves’ illness and difficult-to-treat rheumatoid arthritis.

While we admit the imaginable of ROIV arsenic an investment, we judge definite AI stocks connection greater upside imaginable and transportation little downside risk. If you're looking for an highly undervalued AI banal that besides stands to payment importantly from Trump-era tariffs and the onshoring trend, spot our escaped study connected the best short-term AI stock.

READ NEXT: 10 Best Magic Formula Stocks for 2025 and 10 Best Retirement Stocks to Buy According to Hedge Funds.

Disclosure: None. This nonfiction is primitively published at Insider Monkey.